If the new drug Ozanimod achieves blockbuster status, it could generate tens of millions of dollars a year in royalties for the Scripps Research Institute. Ozanimod, a drug that slows brain atrophy in patients with multiple sclerosis, was discovered at Scripps and is expected to be marketed by Celgene (Nasdaq: CELG) to MS patients in late 2018.
From limb-lengthening procedures to removing skin cancer without a scar, two innovative Palm Beach County medical operations are making a difference in both patients’ lives and in the local economy.
One of the reasons for establishing the JLSI on the MacArthur campus was to enhance collaborations with The Scripps Research Institute. The success of this endeavor is illustrated by a number of publications in the past year. In the past year alone there have been at least 7 joint publications between The Scripps Research Institute and FAU. These publications involve 11 faculty; 5 at FAU and 6 at Scripps. The projects have a common theme in exploring the development and function of the nervous system using genetic and molecular methods.
Modernizing Medicine, Inc., creator of the Electronic Medical Assistant® (EMA™), announced its specialty-specific electronic health record (EHR) systems for dermatology, otolaryngology and plastic surgery earned the #1 spots on the Black Book Research Top EHR lists in those spaces. This is the third year in a row Modernizing Medicine has ranked #1 in the dermatology category, the second year the company has ranked #1 in the otolaryngology market and the first year the company has ranked #1 in the plastic surgery space.
Palm Beach County is home to 84 life sciences businesses, but more work is needed to build a thriving economic sector in the region, according to a study released Monday.
The Palm Beach County’s Business Development Board revealed a study pointing to the strengths, weaknesses, opportunities and threats in its mission to build a sustainable life science sector.
The report recommends:
• Creating a life science leadership group.
• Fostering awareness of what exists through marketing.
• Identifying industry players who have homes or other investments in South Florida to become involved.
• Enhancing the networking effort.
• Developing a regional identification and identity.
• Providing resources and support to both existing companies and startups.
• Partnering with Florida Atlantic University and other regional universities and life science institutes to catalyze entrepreneurial efforts.
First, the region must agree on an identity for the life science sector and communicate that to the industry’s key players to attract new investment, community leaders said at a meeting unveiling the study.
Modernizing Medicine, Inc., the creator of the Electronic Medical Assistant® (EMA™), a cloud-based, specialty-specific electronic health record (EHR) system, will showcase its latest suite of specialty-specific products at the 2016 HIMSS Annual Conference in Las Vegas. Modernizing Medicine has significantly expanded its offerings over the past year, through both organic innovation and the acquisition of leading gastroenterology and ambulatory surgery center (ASC) solutions provider gMed. This year’s HIMSS conference will be the first time the company will showcase its new and expanded suite, including solutions designed specifically for ASCs.
Building on the early success of its flagship EHR solution, EMA, Modernizing Medicine’s new expanded suite of products and services now includes:
modmed EMA™ – modmed EMA is a specialty-specific EHR system designed by physicians for physicians to support streamlined workflows, improved care and quality reporting.
The University of Miami announced Thursday it has received a $50 million donation to build a new state-of-the-art building to house its medical program. Nova Southeastern University just named a dean for its soon-to-open second medical school, while Florida Atlantic University and Florida International University have been adding more residency programs to train young doctors.
A medical education expansion is needed, experts say, because two state health groups are predicting Florida will be short 7,000 physicians by 2025.
Charleston Laboratories, Inc. is expanding operations and creating a modest number of jobs in Palm Beach County. The privately held company will retain six existing jobs and create 25 more this year thanks to efforts by the Business Development Board of Palm Beach County, in cooperation with Enterprise Florida, the Florida Department of Economic Opportunity and the Town of Jupiter.
Charleston Laboratories is in the process of making a capital investment of $4 million in the purchase and renovation of an office building located at 1150 North US Hwy 1 in Jupiter. The company has commenced renovations at its headquarters and will begin hiring this month. The company received a Florida Qualified Target Industry Tax Refund of $140,000 from the State and an additional $35,000 in incentives from the Town of Jupiter.
A pharmaceutical company that moved its corporate headquarters to Jupiter a year ago is spending about $4 million to buy and refurbish a U.S. 1 office building for expansion.
“Our slogan is “See it big but keep it simple.” We hope to help millions of patients worldwide,” said Paul Bosse, the president and Chief Executive Officer of Charleston Laboratories Inc., a privately owned company that started in 2007.